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Abstract
Background: Hepatocellular adenoma (HCA) is a rare benign liver epithelial tumour that can require
surgery. This retrospective study reports a 23-year experience of open and laparoscopic resections for
HCA.
Methods: Patients with a histological diagnosis of HCA were included in this analysis. Surgical resection
was performed in all symptomatic patients and in those with lesions measuring > 5 cm.
Results: Between 1989 and 2012, 62 patients, 59 of whom were female, underwent surgery for HCA (26
by open surgery and 36 by laparoscopic surgery). Overall, 96.6% of female patients had a history of
contraceptive use; 54.8% of patients presented with abdominal pain and 11.2% with haemorrhage; the
remaining patients were asymptomatic. Patients who underwent laparoscopy had smaller lesions (mean
± standard deviation diameter: 68.3 ± 35.2 mm versus 91.9 ± 42.5 mm; P = 0.022). Operatively,
laparoscopic and open liver resection did not differ except in the number of pedicle clamps, which was
significantly lower in the laparoscopic group (27.8% versus 57.7% of patients; P = 0.008). Postoperative
variables did not differ between the groups. Mortality was nil. Two surgical specimens were classified as
HCA/borderline hepatocellular carcinoma. At the 3-year follow-up, all patients were alive with no recur-
rence of HCA.
Conclusions: Open and laparoscopic liver resections are both safe and feasible approaches for the
surgical management of HCA. However, laparoscopic liver resections may be limited by lesion size and
location and require advanced surgical skills.
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Introduction
Although rare, hepatocellular adenoma (HCA) is the most
common benign epithelial tumour of the liver.1 First described by
Edmondson in 1958,2 the incidence of HCA has progressively
increased since the 1970s to reach approximately three cases per
million population per year, of which 90% occur in women.3 This
trend may be explained by the wide use of oral oestrogen-based
contraceptives among young women, combined with the increas-
ing quality and number of liver imaging techniques.1 Recently,
distinct subtypes of HCA, based on molecular alterations, have
been identified.4 These types are: (i) H-HCA, in which inactivat-
ing mutations of the gene are encoded by hepatocyte nuclear
factor-1α (HNF-1α); (ii) β-HCA, which shows a β-catenin-
activating mutation; (iii) I-HCA, which represents inflammatory
HCA, and (iv) U-HCA, which represents unclassified HCA.4
Either H-HCA or I-HCA is found in 80% of patients, whereas
β-HCA is found in approximately 10–15%. The I-HCA subtype
accounts for 40–50% of all adenomas and has been demonstrated
to be associated with alcohol abuse and obesity.5 Recently, new risk
factors for HCA have emerged, including metabolic syndrome,5
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use of clomiphene, methyltestosterone or danazol, Klinefelter’s
syndrome, types Ia, Ib and III glycogen storage disease,6 and famil-
ial adenomatous polyposis.1 Hepatocellular adenoma is usually a
solitary tumour of variable size, but in 10–24% of patients it
presents with multiple nodules; the presence of more than 10
nodules is defined as liver adenomatosis.7–9 Symptoms can be
related to tumour size or to specific complications. Size-related
symptoms are usually non-specific, such as right upper quadrant
tenderness, dyspepsia or abdominal mass presentation. A specific
and potentially life-threatening complication of HCA is tumour
rupture with haemorrhage, observed in 20–40% of patients.10–12
Malignant transformation affects up to 10% of patients and does
not distinguish between isolated HCA and liver adenomatosis.1
Diagnosis is based on multi-phase spiral computed tomogra-
phy (CT) and multi-phase contrast-enhanced magnetic reso-
nance imaging (MRI), but a definitive diagnosis is possible only
after a histopathological examination.13,14 Biopsy can be useful in
subtyping HCA, but is not always recommended for diagnosis
because it can induce bleeding and tumour dissemination.15,16
Moreover, biopsy cannot completely rule out the occurrence of
malignant transformation.17 Although there has been no consen-
sus on the management of HCA, surgical resection is generally
indicated for tumours larger than 5 cm, in symptomatic patients,
or when there is strong concern regarding malignant transfor-
mation.18,19 For liver adenomatosis, liver transplantation is the
only cure because of the frequent bilobar distribution of the
lesions.20
The application of laparoscopic liver surgery in benign diseases
was first reported in 1991.21 Since then, many authors have pre-
sented series of patients submitted to laparoscopic resection for
benign liver tumours.22 Although there has been a lack of inter-
national guidelines, the laparoscopic approach has been used
mainly in patients with peripheral lesions located in the left lateral
(segments II and III) and anterior (segments IVb, V and VI) liver,
which have required limited resections.23–25 However, major
laparoscopic liver resections (more than three segments) have also
been reported with successful outcomes when performed by
experienced surgeons in specialized centres.23,26–28
The few studies in the literature that have reported the
laparoscopic management of liver adenomas have mostly
described heterogeneous populations of patients presenting with
different benign liver diseases requiring surgery.22,23,29 The aim of
the present study was to report the 23-year experience of a spe-
cialist hepatobiliary unit in the surgical resection of HCA,
managed by both open and laparoscopic approaches. The indica-
tions, outcomes, complications and advantages of both techniques
are discussed.
Materials and methods
This was a retrospective study of a prospectively maintained data-
base on HCAs. Demographic, preoperative, operative and postop-
erative data for patients diagnosed with HCA and submitted to
surgery between 1989 and 2012 were retrieved and analysed after
institutional board approval.
Patients were included in the study if the diagnosis of HCA had
been confirmed by a histopathological analysis of the surgical
specimen. All resected HCAs were classified using common his-
tological and immunohistochemical criteria.30
Surgical resection was performed in all symptomatic patients
and in those with lesions measuring >5 cm. Patients with
polyadenomatosis (≥10 nodules) were excluded.
Prior to surgery, all patients underwent imaging including
abdominal ultrasound, multi-phase spiral CT and multi-phase
contrast-enhanced MRI. Liver biopsy was performed selectively
when preoperative imaging was unclear. Each patient was individ-
ually evaluated in a multidisciplinary meeting during which the
best surgical approach and technique were collegially discussed
and chosen.
The surgeries were performed using either an open or a
laparoscopic approach on a patient-by-patient basis. The main
clinical criteria used to select the surgical technique were lesion
size and location (i.e. proximity to major vascular structures) and,
consequently, the extent of hepatic tissue (i.e. segments) that
required to be resected. Surgical decisions were based on imaging
studies. Both elective and emergency settings were included.
Emergency surgery was performed when tumour rupture was
identified, based on clinical symptoms and radiological findings.
The surgeries included all types of liver resection (e.g.major resec-
tion, bisegmentectomy, segmentectomy, wedge resection), per-
formed according to the location and size of the tumour. The
Pringle manoeuvre was not used as a routine procedure.
The same team has previously described laparoscopic liver
resection performed using the standard nomenclature.22,31 Major
hepatectomy was defined as resection of three or more liver seg-
ments, whereas minor hepatectomy included segmentectomy,
bisegmentectomy and wedge procedures.22,32 For open liver resec-
tion, a right subcostal incision, with or without an upper midline
extension, was performed. Crush and clamp techniques,
oversewing of biliary ducts, monopolar and bipolar cautery, and,
more recently, the Cavitron ultrasonic surgical aspirator (CUSA;
Tyco Healthcare, Covidien, Inc., Mansfield, MA, USA) and vascu-
lar stapler were used. For laparoscopic liver resections, liver paren-
chyma transection was performed using a combination of the
LigaSure (Valleylab, Covidien, Inc.), the Harmonic Scalpel
(Ethicon EndoSurgery, Inc., Cincinnati, OH, USA), the Endo GIA
vascular stapler (US Surgical Corp., Norwalk, CT, USA), and
bipolar cautery. In all patients, prior to surgical transection,
intraoperative liver ultrasound was performed to guide and limit
the resection margins.
After liver resection, patients were included in a 1-year and
3-year follow-up protocol. The following variables were analysed:
patient demographics [e.g. age, sex, body mass index (BMI),
medications taken]; imaging studies; laboratory tests; biopsies;
surgical technique (i.e. open or laparoscopic); surgical complica-
tions (e.g. duration, conversion, blood loss); tumour characteris-
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tics (e.g. number, size, location), and short- and longterm
postoperative variables (e.g. Clavien–Dindo classification, dura-
tion of hospital stay, incisional hernia, recurrence after resection).
Moreover, when available, histological slides were re-reviewed
for this analysis and HCAs were classified as H-HCA, β-HCA,
I-HCA, U-HCA or HCA/borderline hepatocellular carcinoma
(HCC) according to the widely recognized system of molecular
classification.4,5
According to data distribution, parametric (Fisher’s exact test)
and non-parametric (Mann–Whitney U-test) statistics were used
to describe the study population and to compare patients submit-
ted to laparoscopic versus open liver resection for HCA. Regres-
sion analyses were performed to control the effects of covariables
on clinical outcomes. A P-value of ≤0.05 was considered to indi-
cate statistical significance. IBM spss Statistics for Macintosh
Version 20.0 (IBM Corp., Armonk, NY, USA) and sas Version 9.2
(SAS Institute, Inc., Cary, NC, USA) were used for statistical
analyses.
Results
Of the 1534 patients in whom liver resections were performed
between 1989 and 2012, a total of 62 underwent surgical resection
for HCA. Only five patients presented with polyadenomatosis;
these patients were excluded from this analysis.
Patient demographics by operative approach are shown in
Table 1. Overall, 96.6% of female patients had taken oestrogen-
based oral contraceptive pills at some time during their lives. At
the time of HCA diagnosis, 23.7% of the women were in meno-
pause. None had familial histories of benign or malign liver
tumours. Five (8.1%) patients had diabetes, five (8.1%) patients
had arterial hypertension, one (1.6%) patient presented with
coronary disease, one (1.6%) patient had chronic kidney failure,
and three (4.8%) patients were diagnosed with dyslipidaemia.
Overall, the demographic and clinical variables did not differ
between the group operated on by laparoscopy and the group
operated on by laparotomy. Conversely, the two groups showed
significant differences in lesion size and type of liver resection;
these variables were taken into account in the regression analysis
(Table 1).
Of the seven patients presenting with tumour rupture and
haemorrhage, six were first treated with selective arterial
embolization and then submitted to surgery in elective settings
(three by laparoscopic and three by open approach), whereas one
patient, in whom haemodynamic stability was not achieved,
underwent surgery in an emergency setting (open liver resection).
Operative factors by type of intervention are shown in Table 2.
In the laparoscopic group, three interventions were converted to
laparotomy as a result of haemorrhage (caused by endovascular
stapler malfunction, difficult exposition, and extreme paren-
chyma fragility during transection). All three patients were under-
going right hepatectomy.
Overall, 22 specimens were not available for re-evaluation or
re-classification. Of the remaining 40 that were retrieved, HCAs
Table 1 Demographics, presentation and treatment in 62 patients submitted to liver resection (LR) for hepatocellular adenoma
Laparoscopic LR (n = 36) Open LR (n = 26) P-value
Age, years, mean ± SD 35.4 ± 9.3 37.7 ± 8.3 0.382
Female, n 35 24 0.374
BMI, kg/m2, mean ± SD 19.8 ± 4.7 22. ± 5.6 0.101
More than one comorbidity, n 10 5 0.375
Use of oral contraceptives, n 35 22 0.072
Increased AFP, >10 ng/ml, n 0 0 0.996
Child–Pugh class A status, n 36 26 0.994
Fatty liver disease, n 3 2 0.882
Bleeding adenoma, n 3 4 0.383
Symptomatic patients, n 20 14 0.894
Number of lesions, median (range) 2 (1–6) 1.5 (1–4) 0.369
Diameter of lesion, mm, median (range) 50.5 (25–130) 95.0 (20–180) 0.030
Emergency hepatectomy, n 0 1 0.424
Type of resection, n 0.044
Major 9 14
Bisegmentectomy 12 3
Segmentectomy 3 1
Wedge 12 8
P-values in bold indicate statistical significance (P ≤ 0.05).
SD, standard deviation; BMI, body mass index; AFP, α-fetoprotein.
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were classified as follows: I-HCA, n = 19; H-HCA, n = 9; U-HCA,
n = 9; β-HCA, n = 1, and HCA/borderline HCC, n = 2. The only
two patients with HCA/borderline HCC lesions had α-fetoprotein
levels within the normal limits and were asymptomatic (no bleed-
ing). They were both managed in elective surgical settings using a
laparoscopic approach in one and laparotomy in the other.
Postoperative variables did not differ between the two groups
(Table 3). Of the three patients in the laparoscopic liver resection
group in whom postoperative complications occurred (within 1
month), two were converted to laparotomy during the surgical
intervention (both major liver resections). The overall mortality
was nil.
At the 1-year follow-up (data available for all 62 patients), all
patients were alive without recurrence of HCA. Three incisional
hernias were observed in the open liver resection group (11.5%)
and one (2.8%) in the laparoscopic group (P = 0.346). At the
3-year follow-up (data available for 53 patients only), all patients
were alive with no recurrence of HCA.
Discussion
The present study describes the clinical outcomes of open and
laparoscopic liver resection performed in 62 patients with HCA.
Over the last two decades, the incidence of HCA appears to have
increased, but, by contrast with findings reported in a recent
review,33 surgical need does not seem to have been influenced
drastically by improvements in the diagnosis of HCA or by the
introduction of laparoscopy.22 Indeed, the availability of a differ-
ent surgical approach cannot change the indications for surgery.
Today, in the management of benign liver pathologies, it is widely
accepted that surgery should be reserved for selected patients
with symptomatic tumours or tumours larger than 5 cm in size,
or in whom there is diagnostic doubt regarding the presence of
HCC. In fact, it has been shown that the great majority (96%) of
HCAs complicated by malignant transformation measure
> 5 cm.18 For asymptomatic HCAs or lesions of <5 cm, a ‘wait-
and-see’ approach can be applied and the discontinuation of oral
contraceptives is recommended.34,35 Moreover, less invasive
approaches, such as radiofrequency ablation and arterial
embolization, may be favourable although their efficacy is still
under evaluation.36,37
In liver resections for benign liver tumours, morbidity rates
have ranged from 10% to 27% and mortality rates from 0% to
3%.22,23,29,38,39 From this perspective, the correct selection of can-
didate patients for surgery is essential,22,40 but the choice between
the laparoscopic and open surgical approaches is still mainly
empirical. According to some authors, laparoscopic liver resection
is more favourably indicated for isolated lesions, lesions of ≤5 cm,
and lesions located in peripheral liver segments II–VI.24 However,
successful major laparoscopic hepatectomies (e.g. right hepatec-
tomy and extended liver resection) have been reported in special-
ized high-volume liver and laparoscopic surgical centres.19,23,26,28
Table 2 Operative variables in 62 patients submitted to liver resection (LR) for hepatocellular adenoma
Laparoscopic LR
(n = 36)
Open LR
(n = 26)
P-value Adjusted
P-valuea
Duration of hepatectomy, min, median (range) 165 (90–390) 180 (90–320) 0.829 0.214
Pringle manoeuvre, n 10 15 0.021 0.009
Conversion, n 3 NA
Blood loss, ml, median (range) 200 (50–1600) 250 (50–2500) 0.428 0.883
RBC units transfused, n 0 2 0.175 NA
P-values in bold indicate statistical significance (P ≤ 0.05).
aRegression analysis for type of liver resection (major versus minor) and tumour size.
RBC, red blood cells; NA, not applicable.
Table 3 Postoperative variables in 62 patients submitted to liver resection (LR) for hepatocellular adenoma
Laparoscopic LR
(n = 36)
Open LR
(n = 26)
P-value Adjusted
P-valuea
Duration of hospitalization, days, median (range) 7.5 (3–26) 6.5 (2–28) 0.528 0.955
Postoperative complications, n 3 5 0.206 0.152
Haemorrhage 1 2
Liver failure 0 2
Biliary leak 1b 1
Sepsis 1b 0
Complications Clavien–Dindo Grade III, IV, n 3 4 0.439 1
aRegression analysis for type of liver resection (major versus minor) and tumour size.
bConverted to laparotomy.
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According to the present results, despite the different tumour
sizes and consequent types of liver resection, no differences in
clinical outcomes or complication rates were observed between
open and laparoscopic liver resections for HCA. The only differ-
ence was observed operatively in terms of the frequency of the
Pringle manoeuvre, which was more frequently performed during
open surgery.
It appears that open and laparoscopic liver resections are
equivalently successful approaches for the surgical management
of HCA. However, whereas in minor hepatectomy tumour size
may not be a limiting factor for laparoscopy,23,41 tumour size and
proximity to hepatic vessels remain the principal criteria guiding
surgical decisions in major hepatectomy.29 In this specialist
hepatobiliary unit, major hepatectomies were performed using
laparoscopy for lesions of up to 13 cm with successful clinical
outcomes. The only three laparoscopic conversions (4.8%) in the
present series occurred in the first major hepatectomies to be
performed via laparoscopy and thus may reflect the effect of a
surgical learning curve. However, laparoscopic major hepatec-
tomy remains a complex and challenging procedure.
In the present study, seven patients (11.3%) presented with
bleeding HCA, representing a lower percentage than previously
reported for haemorrhagic HCA in the literature (assessed at
approximately 20–30%).23,29 All bleeding adenomas weremanaged
by selective arterial embolization to achieve haemodynamic sta-
bility before the patient was submitted to elective laparoscopic or
open surgery. Only one patient underwent emergency surgery;
arterial embolization was not possible as a result of this patient’s
extremely unstable condition. This emergency surgery was per-
formed using an open surgery approach, but other previous
patient series have reported the successful management of haem-
orrhagic HCA by laparoscopy.19
Of the 62 patients with HCA submitted to surgery, only two
(3.2%) presented with a borderline malignant transformation.
This finding supports the unknown but certainly low rate of
malignancy in this liver tumour,18,29,34 as well as the clear advantage
of surgical resection in preventing disease complications and evo-
lution. To date, surgical indications have been based mainly on the
morphological and clinical characteristics of HCAs, but it is pos-
sible that in the near future the HCA genetic profile may be
considered within the assessment of need for surgery and patient
risk because the H-HCA subtype is known to pose a greater risk
for bleeding and the β-catenin mutation HCA is more likely to
develop malignant transformation.4,42 However, the innate limita-
tions of hepatic biopsy are associated with a low sensitivity for the
detection of HCA malignancy and are aggravated by an increased
risk, albeit small, for major haemorrhage.15,43 At present, surgical
resection is the only way to ensure the definitive diagnosis, char-
acterization and treatment of HCAs.
In conclusion, in the absence of an international consensus and
guidelines, each centre may define its own protocol for the indi-
cations for and type of resection, based on its own surgical experi-
ence and on the morphological characteristics of the HCA. It
appears that for minor liver resections, the laparoscopic approach
is safe and feasible, and should be routinely performed. Major
hepatectomy, however, requires advanced surgical skills if it is to
be performed through laparoscopy and the feasibility of this
approach appears to be limited by lesion size and location.
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